Clearstead Advisors’s Cullen/Frost Bankers CFR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.81K Buy
57
+42
+280% +$5.96K ﹤0.01% 2020
2026
Q1
$2.06K Sell
15
-213
-93% -$29.4K ﹤0.01% 1890
2025
Q4
$28.9K Sell
228
-90
-28% -$11.3K ﹤0.01% 1599
2025
Q3
$40.3K Sell
318
-1,922
-86% -$250K ﹤0.01% 1348
2025
Q2
$288K Buy
2,240
+167
+8% +$20.4K ﹤0.01% 778
2025
Q1
$260K Sell
2,073
-115
-5% -$15.4K ﹤0.01% 747
2024
Q4
$294K Buy
2,188
+1,283
+142% +$169K ﹤0.01% 732
2024
Q3
$101K Sell
905
-116
-11% -$12.7K ﹤0.01% 1027
2024
Q2
$104K Buy
1,021
+990
+3,194% +$104K ﹤0.01% 989
2024
Q1
$3.33K Hold
31
﹤0.01% 1236
2023
Q4
$3.36K Sell
31
-31
-50% -$3.01K ﹤0.01% 1218
2023
Q3
$5.66K Buy
+62
New +$6.29K ﹤0.01% 1217
2023
Q2
Sell
-280
Closed -$29.5K 1391
2023
Q1
$29.5K Buy
+280
New +$34.9K ﹤0.01% 774
2021
Q4
Sell
-224
Closed -$27K 1295
2021
Q3
$27K Buy
+224
New +$25K ﹤0.01% 722

Other funds holding CFR

Clearstead Advisors's CFR Position: Q2 2026 in Review

Clearstead Advisors increased its Cullen/Frost Bankers (CFR) stake by 280% in Q2 2026, buying an estimated $5.96K and bringing the position to 57 shares worth $8.81K. The position accounts for ﹤0.01% of the portfolio, ranked #2020.

Clearstead Advisors first reported a position in CFR in Q3 2021 and has held it in 14 quarters since. The position peaked at $294K in Q4 2024. 566 funds tracked by Wall St. Rank hold CFR as of Q2 2026.

  • Clearstead Advisors held 57 shares of Cullen/Frost Bankers worth $8.81K as of Q2 2026.
  • Clearstead Advisors bought 42 Cullen/Frost Bankers shares in Q2 2026, an estimated $5.96K.
  • Cullen/Frost Bankers made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2020 holding.
  • Clearstead Advisors first reported a position in Cullen/Frost Bankers in Q3 2021 and has held it in 14 quarters since.
  • Clearstead Advisors's Cullen/Frost Bankers position peaked at $294K in Q4 2024.
  • 566 funds tracked by Wall St. Rank held Cullen/Frost Bankers as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.